Cannara Biotech Inc (8CB0.SG)
Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
As of 10:10AM CEST. Market open.
| Previous close | 0.4580 |
| Open | 0.4600 |
| Bid | 0.4580 x N/A |
| Ask | 0.5150 x N/A |
| Day's range | 0.4600 - 0.4600 |
| 52-week range | 0.4520 - 0.7350 |
| Volume | |
| Avg. volume | 87 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Cannara Biotech Second Quarter 2024 Earnings: CA$0.038 loss per share (vs CA$0.007 loss in 2Q 2023)
Cannara Biotech ( CVE:LOVE ) Second Quarter 2024 Results Key Financial Results Revenue: CA$19.7m (up 51% from 2Q 2023...
- Market Exclusive
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Key Takeaways; Cannabis Sector Key Takeaways; Psychedelic Sector Below is a weekly roundup on the cannabis and psychedelic sectors. In this ever-evolving landscape, we explore the major developments and groundbreaking initiatives happening among companies operating in these industries; from advancements in medical research, therapeutic applications to shifts in legal frameworks and current market trends. Top […]
- Simply Wall St.
The past five years for Cannara Biotech (CVE:LOVE) investors has not been profitable
We think intelligent long term investing is the way to go. But along the way some stocks are going to perform badly...
© 2024 Yahoo. All rights reserved.